You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Relapsed Small Cell Lung Cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Small Cell Lung Cancer (SCLC) Trial (Tarlatamab, Lurbinectedin, Topotecan)

Not yet recruiting
  • Small Cell Lung Cancer (SCLC)
  • (no location specified)
Feb 21, 2023

Small Cell Lung Cancer Trial in Seoul (Durvalumab)

Active, not recruiting
  • Small Cell Lung Cancer
  • Seongnam-si, Gyeonggi-do, Korea, Republic of
  • +1 more
Nov 6, 2022

Relapsed Small Cell Lung Cancer Trial in Beijing (Irinotecan HCl liposome Injection, Topotecan)

Not yet recruiting
  • Relapsed Small Cell Lung Cancer
  • Irinotecan hydrochloride liposome Injection
  • Topotecan
  • Beijing, China
    Cancer Hospital, Chinese Academy of Medical Sciences
Nov 7, 2023

Small-cell Lung Cancer, Small Cell Lung Carcinoma Trial in Pittsburgh (Onvansertib)

Recruiting
  • Small-cell Lung Cancer
  • Small Cell Lung Carcinoma
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Jul 29, 2022

Small-cell Lung Cancer, Relapsed Small Cell Lung Cancer, Recurrent Small Cell Lung Cancer Trial in Kissimmee, Tampa (Nivolumab,

Recruiting
  • Small-cell Lung Cancer
  • +2 more
  • Kissimmee, Florida
  • +1 more
Nov 2, 2022

Lung Cancer Trial in Korea, Republic of (Olaparib+Bevacizumab to SCLC patients)

Recruiting
  • Lung Cancer
  • Olaparib+Bevacizumab to SCLC patients
  • Seoul, Gangnam-gu, Korea, Republic of
  • +3 more
Nov 9, 2022

Small-cell Lung Cancer, Small Cell Lung Carcinoma Trial in Saint Louis (Mycophenolate Mofetil, Allopurinol, Irinotecan)

Not yet recruiting
  • Small-cell Lung Cancer
  • Small Cell Lung Carcinoma
  • Mycophenolate Mofetil
  • +2 more
  • Saint Louis, Missouri
    Washington University School of Medicine
May 17, 2022

Extensive Stage Small Cell Lung Cancer Trial (hSTC810 400 mg + Paclitaxel, hSTC810 800 mg + Paclitaxel)

Not yet recruiting
  • Extensive Stage Small Cell Lung Cancer
  • hSTC810 400 mg + Paclitaxel
  • hSTC810 800 mg + Paclitaxel
  • (no location specified)
Aug 24, 2023

SCLC, Recurrent Trial in Seoul (Durvalumab+AZD2811 to SCLC patients)

Terminated
  • SCLC, Recurrent
  • Durvalumab+AZD2811 to SCLC patients
  • Seoul, Gangnam-gu, Korea, Republic of
    Samsung Medical Center
Feb 8, 2022

Metastatic Malignant Solid Tumor, Recurrent Lung Small Cell Carcinoma, Recurrent Malignant Solid Tumor Trial in United States

Terminated
  • Metastatic Malignant Solid Neoplasm
  • +8 more
  • Los Angeles, California
  • +13 more
Oct 7, 2022

NSCLC Trial (Tirelizumab;Chemotherapy monotherapy)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • Tirelizumab；Chemotherapy monotherapy
  • (no location specified)
Jul 27, 2023

Small Cell Lung Carcinoma Trial in Barcelona, Madrid (Lurbinectedin, Pembrolizumab)

Recruiting
  • Small Cell Lung Carcinoma
  • Barcelona, Spain
  • +4 more
Aug 12, 2022

Small Cell Lung Cancer Trial in Beijing (Chiauranib, Placebo)

Recruiting
  • Small Cell Lung Cancer
  • Beijing, Beijing, China
    Cancer Hospital, Chinese Academy of Medical Sciences
May 4, 2022

Urothelial Carcinoma, Urothelial Cancer, Lung Tumors Trial run by the NCI (EP0057, olaparib)

Recruiting
  • Urothelial Carcinoma
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Extensive-stage Small Cell Lung Cancer Trial in Tianjin (Selinexor,Olaparib)

Recruiting
  • Extensive-stage Small Cell Lung Cancer
  • Tianjin, China
    Tianjin Medical University Cancer Institute and Hospital
Jul 27, 2023

Small Cell Lung Carcinoma, Neuroendocrine Tumors Trial (BI 764532)

Not yet recruiting
  • Small Cell Lung Carcinoma
  • Neuroendocrine Neoplasms
  • BI 764532
  • (no location specified)
May 22, 2023

Platinum-Resistant Lung Small Cell Carcinoma, Platinum-Sensitive Lung Small Cell Carcinoma, Recurrent Extensive Stage Lung Small

Recruiting
  • Platinum-Resistant Lung Small Cell Carcinoma
  • +3 more
  • Durvalumab
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 5, 2023

Small Cell Lung Cancer Trial (SC0245, Irinotecan)

Not yet recruiting
  • Small Cell Lung Cancer
  • (no location specified)
Feb 7, 2023

Small-cell Lung Cancer Trial in Canton (Chiauranib)

Recruiting
  • Small-cell Lung Cancer
  • Canton, Ohio
    Gabrail Cancer Center Research
Jul 27, 2022

Lung Cancer, Bronchial Cancer, Non Small Cell Lung Cancer Trial in Anqing (Recombinant oncolytic herpes simplex virus type 1

Recruiting
  • Lung Cancer
  • +11 more
  • Recombinant oncolytic herpes simplex virus type 1 (R130)
  • Anqing, Anhui, China
    The PLA Navy Anqing Hospital
May 23, 2023

Non Small Cell Lung Cancer Trial in Leiden, Rotterdam (TEIPP24 (LRPAP7-30V-SLP vaccine in Montanide ISA-51))

Recruiting
  • Non Small Cell Lung Cancer
  • TEIPP24 (LRPAP7-30V-SLP vaccine in Montanide ISA-51)
  • Leiden, Zuid-Holland, Netherlands
  • +1 more
Jun 1, 2023

Umbrella Trial in Relapsed Small Cell Lung Cancer Patients

Recruiting
  • Small Cell Lung Cancers
  • No treatment is included in this protocol.
  • Seoul, Korea, Republic of
    Se-Hoon Lee
Aug 26, 2021

Relapsed or Advanced NSCLC Trial (Almonertinib combined with SHR-1701, Almonertinib)

Not yet recruiting
  • Relapsed or Advanced Non-small Cell Lung Cancer
  • (no location specified)
Aug 16, 2022

Small Cell Lung Cancer Trial in Changsha (Anlotinib Plus Penpulimab)

Recruiting
  • Small Cell Lung Cancer
  • Anlotinib Plus Penpulimab
  • Changsha, Hunan, China
    Nong Yang
Aug 11, 2021

Recurrent Extensive Stage Small Cell Lung Carcinoma, Refractory Extensive Stage Small Cell Lung Carcinoma Trial in United States

Active, not recruiting
  • Recurrent Extensive Stage Small Cell Lung Carcinoma
  • Refractory Extensive Stage Small Cell Lung Carcinoma
  • Bakersfield, California
  • +5 more
Jan 5, 2023